XML 50 R38.htm IDEA: XBRL DOCUMENT v3.6.0.2
Other Real Estate Property Investments (Tables)
12 Months Ended
Dec. 31, 2016
Acquisition  
Schedule of real estate acquisitions (in thousands)

The following table summarizes real estate acquisitions for the year ended December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consideration

 

Assets Acquired(1)

 

 

 

 

 

Liabilities

 

 

 

 

Net

 

Segment

    

Cash Paid

    

Assumed

    

Real Estate

    

Intangibles

 

SH NNN

 

$

76,362

 

$

1,200

 

$

71,875

    

$

5,687

 

SHOP

 

 

113,971

 

 

76,931

 

 

177,551

 

 

13,351

 

Life science

 

 

49,000

 

 

 —

 

 

47,400

 

 

1,600

 

Medical office 

 

 

209,920

 

 

4,854

 

 

209,178

 

 

5,596

 

Other

 

 

17,909

 

 

 —

 

 

16,596

 

 

1,313

 

 

 

$

467,162

 

$

82,985

 

$

522,600

 

$

27,547

 


(1)

The purchase price allocations are preliminary and may be subject to change. Revenues and earnings since the acquisition dates, as well as the supplementary pro forma information, assuming these acquisitions occurred as of the beginning of the prior periods, were not material.

Schedule of capital improvements (in thousands)

The following table summarizes the Company’s funding for construction, tenant and other capital improvements (in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

Segment

    

2016

    

2015

 

SH NNN

 

$

49,109

 

$

53,980

 

SHOP

 

 

74,158

 

 

77,425

 

Life science

 

 

200,122

 

 

122,319

 

Medical office

 

 

128,308

 

 

131,021

 

Other

 

 

7,203

 

 

37

 

 

 

$

458,900

 

$

384,782

 

 

RIDEA III  
Acquisition  
Schedule of unaudited pro forma consolidated results of operations (in thousands, except per share amounts)

The following unaudited pro forma consolidated results of operations assume that the RIDEA III acquisition was completed as of January 1, 2014 (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

    

December 31, 2015

    

December 31, 2014

 

Revenues

 

$

2,034,369

 

$

1,824,593

 

Net (loss) income

 

 

(531,464)

 

 

954,540

 

Net (loss) income applicable to HCP, Inc.

 

 

(545,776)

 

 

938,387

 

Basic earnings per common share

 

$

(1.18)

 

$

2.04

 

Diluted earnings per common share

 

 

(1.18)

 

 

2.04

 

 

Other real estate acquisitions  
Acquisition  
Schedule of real estate acquisitions (in thousands)

In addition to the RIDEA III acquisition discussed above, the following table summarizes other real estate acquisitions for the year ended December 31, 2015 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consideration

 

Assets Acquired(1)

 

 

 

Cash Paid/

 

Liabilities

 

Noncontrolling

 

 

 

 

Net

 

Segment

    

Debt Settled

    

Assumed

    

Interest

    

Real Estate

    

Intangibles

 

SH NNN

 

$

208

 

$

 —

 

$

 —

 

$

208

    

$

 —

 

SHOP

 

 

151,054

 

 

1,443

 

 

4,255

 

 

147,296

 

 

9,456

 

Life science

 

 

80,946

 

 

2,054

 

 

 —

 

 

68,988

 

 

14,012

 

Medical office(2)

 

 

384,114

 

 

12,866

 

 

 —

 

 

305,091

 

 

91,889

 

Other(3)

 

 

296,227

 

 

6,855

 

 

 —

 

 

248,826

 

 

54,256

 

 

 

$

912,549

 

$

23,218

 

$

4,255

 

$

770,409

 

$

169,613

 


(1)

Revenues and earnings since the acquisition dates, as well as the supplementary pro forma information, assuming these acquisitions occurred as of the beginning of the prior periods, were not material.

(2)

Includes $225 million for a medical office building (“MOB”) portfolio acquisition completed in June 2015 and placed in HCP Ventures V, LLC (“HCP Ventures V”), of which in October 2015 the Company issued a 49% noncontrolling interest in HCP Ventures V for $110 million (see Note 13).

(3)

Includes £174 million ($254 million) of the Company’s HC-One Facility (see Note 7) converted to fee ownership in a portfolio of 36 care homes located throughout the United Kingdom (“U.K.”) and includes £27 million ($42 million) of a loan originated in May 2015 converted to fee ownership in two U.K. care homes.